Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer

Jpn J Cancer Res. 1989 Oct;80(10):920-3. doi: 10.1111/j.1349-7006.1989.tb01626.x.

Abstract

c-erbB-2 oncogene has been reported to be frequently amplified in differentiated, tubular type of gastric cancer. Here we report a human gastric cancer which bore co-amplified c-myc and c-erbB-2 oncogenes: a portion of the amplified c-erbB-2 oncogene was found to be rearranged. Furthermore, c-myc and c-erbB-2 oncogenes were over-expressed in the tumor cells. In contrast to the previous reports, this gastric adenocarcinoma was classified as a poorly differentiated type, and was highly tumorigenic in nude mice. These results might suggest that activated c-myc and c-erbB-2 oncogenes co-operate and influence the malignant state of some gastric carcinomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology
  • Animals
  • DNA Probes
  • DNA, Neoplasm / genetics
  • Gene Amplification*
  • Humans
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Nucleic Acid Hybridization
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins c-myc
  • Proto-Oncogenes*
  • Receptor, ErbB-2
  • Stomach Neoplasms / genetics*
  • Stomach Neoplasms / pathology

Substances

  • DNA Probes
  • DNA, Neoplasm
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myc
  • Receptor, ErbB-2